INSMED INC (INSM)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for INSM
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| INSM | Chief Medical Officer | ["More than 25 years in medical and commercial roles in biotechnology and pharmaceutical industry", "Former Senior Vice President at Boehringer Ingelheim", "Various positions at Boehringer Ingelheim from 2012 to 2018", "Roles at Pfizer, Inc. from 2000 to 2011", "MBA from New York University Stern School of Business", "M.D. from University of Vienna Medical School"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Flammer joined Insmed as Chief Medical Officer in December 2019. Dr. Flammer has more than 25 years of experience in both medical and commercial roles in the global biotechnology and pharmaceutical industry. From February 2018 to October 2019, Dr. Flammer was Head of Corporate Division Customer Value, Senior Vice President at Boehringer Ingelheim International. From 2012 to 2018, Dr. Flammer held various positions at Boehringer Ingelheim, including Vice President, Clinical Development and Medical Affairs (2016 - 2018), Vice President of Medicine, Regulatory Affairs & Pharmacovigilance (2014 - 2016), and Senior Global Medical Director, Clinical Development & Medical Affairs Virology (2012 - 2014). Prior to her time at Boehringer Ingelheim, Dr. Flammer served in various roles at Pfizer, Inc. from 2000 to 2011. Dr. Flammer holds a Master of Business Administration from New York University Stern School of Business and an M.D. from University of Vienna Medical School.